Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus

Journal of Gene Medicine

Volumn 5, Issue 9, 2003, Pages 748-756

  Li, Jin Zhong ^a   Hankins, Gerald R ^a   Kao, Chinghai ^b   Li, Hongwei ^a   Kammauff, John ^a   Helm, Gregory A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

BMP 9; Bone formation; Helper dependent adenovirus; Rat

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN; COLLAGEN; GREEN FLUORESCENT PROTEIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 9; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN 9; PHOTOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; COLLAGEN SYNTHESIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; ENZYME ACTIVITY; EX VIVO STUDY; EXPERIMENTAL MODEL; GENE THERAPY; GENETIC TRANSDUCTION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; LEG MUSCLE; MEDICAL ASSESSMENT; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ADENOVIRUS; ANIMAL; BONE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HELPER VIRUS; ISOLATION AND PURIFICATION; LACTOSE OPERON; METABOLISM; NUDE RAT; PLASMID; RADIOGRAPHY; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELPER VIRUSES; HUMANS; LAC OPERON; LUMINESCENT PROTEINS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; PLASMIDS; RATS; RATS, NUDE; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TOMOGRAPHY, X-RAY COMPUTED; TRANSFECTION;

EID: 1342279195     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.412     Document Type: Article

References (41)

1. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-1534.
2. Wozney JM. Bone morphogenetic proteins. Prog Growth Factor Res 1989; 1: 267-280.
3. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 1998; 26-37.
4. Yamashita H, Ten Dijke P, Heldin CH, et al. Bone morphogenetic protein receptors. Bone 1996; 19: 569-574.
5. Ploemacher RE, Engels LJ, Mayer AE, et al. Bone morphogenetic protein 9 is a potent synergistic factor for murine hemopoietic progenitor cell generation and colony formation in serum-free cultures. Leukemia 1999; 13: 428-437.
6. Miller AF, Harvey SA, Thies RS, et al. Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J Biol Chem 2000; 275: 17937-17945.
7. Helm GA, Alden TD, Beres EJ, et al. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg 2000; 92: 191-196.
8. Helm GA, Alden TD, Sheehan JP, et al. Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: a review. Neurosurgery 2000; 46: 1213-1222.
9. Helm GA, Li JZ, Alden TD, et al. A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy. J Neurosurg 2001; 95: 298-307.
10. Kirker-Head CA. Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev 2000; 43: 65-92.
11. Lopez-Coviella I, Berse B, Krauss R, et al. Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science 2000; 289: 313-316.
12. Reddi AH. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 2001; 83-A: S1-6.
13. Rodeo SA, Suzuki K, Deng XH, et al. Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel. Am J Sports Med 1999; 27: 476-488.
14. Varady P, Li JZ, Cunningham M, et al. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther 2001; 12: 697-710.
15. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998; 16: 247-252.
16. Reddi AH. Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage. J Cell Biochem 1994; 56: 192-195.
17. Celeste AJ, Song JJ, Cox K, et al. Bone morphogenetic protein 9, a new member of the TGF-beta superfamily. J Bone Mineral Res 1994; 9: S136
18. Alden TD, Beres EJ, Laurent JS, et al. The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J Craniofac Surg 2000; 11: 24-30.
19. Shen WY, Lai MC, Beilby J, et al. Combined effect of cyclosporine and sirolimus on improving the longevity of recombinant adenovirus-mediated transgene expression in the retina. Arch Ophthalmol 2001; 119: 1033-1043.
20. Harshyne LA, Watkins SC, Gambotto A, et al. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 2001; 166: 3717-3723.
21. Hardy S, Kitamura M, Harris-Stansil T, et al. Construction of adenovirus vectors through Cre-lox recombination. J Virol 1997; 71: 1842-1849.
22. Parks RJ, Chen L, Anton M, et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 1996; 93: 13565-13570.
23. He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95: 2509-2514.
24. Fisher KJ, Choi H, Burda J, et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 1996; 217: 11-22.
25. Morsy MA, Gu M, Motzel S, et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A 1998; 95: 7866-7871.
26. Prophet EB, Mills B, Arrington JB, et al. Laboratory Methods in Histotechnology: American Registry of Pathology, 1992.
27. Gartner LP, Hiatt JL. Color Textbook of Histology, W.B. Saunders, 1997.
28. Fawcett DW, Jensh RP. Bloom and Fawcett: Concise Histology Thomson International Publishing, 1996.
29. Sandig V, Youil R, Bett AJ, et al. Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci U S A 2000; 97: 1002-1007.
30. Parks RJ, Bramson JL, Wan Y, et al. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors. J Virol 1999; 73: 8027-8034.
31. Hoess RH, Abremski K. Mechanism of strand cleavage and exchange in the Cre-lox site-specific recombination system. J Mol Biol 1985; 181: 351-362.
32. Mack A, Sauer B, Abremski K, et al. Stoichiometry of the Cre recombinase bound to the lox recombining site. Nucleic Acids Res 1992; 20: 4451-4455.
33. Abremski K, Wierzbicki A, Frommer B, et al. Bacteriophage P1 Cre-loxP site-specific recombination. Site-specific DNA topoisomerase activity of the Cre recombination protein. J Biol Chem 1986; 261: 391-396.
34. Gambotto A, Dworacki G, Cicinnati V, et al. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Ther 2000; 7: 2036-2040.
35. Jiang ZL, Reay D, Kreppel F, et al. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle. Mol Ther 2001; 3: 892-900.
36. Wold WS, Doronin K, Toth K, et al. Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Curr Opin Immunol 1999; 11: 380-386.
37. Croxford JL, Feldmann M, Chernajovsky Y, et al. Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system. J Immunol 2001; 166: 4124-4130.
38. Sun Q, Turner CH. Two inbred rat strains that differ substantially in hip fragility. Calcif Tissue Int 2003; 15: 15.
39. Wergedal JE, Sheng MH, Ackert-Bicknell CL, et al. Mouse genetic model for bone strength and size phenotypes: NZB/B1NJ and RF/J inbred strains. Bone 2002; 31: 670-674.
40. Linkhart TA, Linkhart SG, Kodama Y, et al. Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities. J Bone Miner Res 1999; 14: 39-46.
41. Sheng MH, Baylink DJ, Beamer WG, et al. Regulation of bone volume is different in the metaphyses of the femur and vertebra of C3H/HeJ and C57BL/6J mice. Bone 2002; 30: 486-491.